Low level laser therapy in the prevention of radiotherapy-induced xerostomia and oral mucositis;Prevenção da xerostomia e da mucosite oral induzidas por radioterapia com uso do laser de baixa potência

Radiologia Brasileira

Volumn 39, Issue 2, 2006, Pages 131-136

  De Oliveira Lopes, Carlos ^a,d   Mas, Josepa Rigau I ^b   Zângaro, Renato Amaro ^c  

^a Instituto de Radioterapia do Vale do Paraíba   (Brazil)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c INSTITUTO DE PESQUISA E DESENVOLVIMENTO   (Brazil)

^d NONE   (Brazil)

Author keywords

Chemotherapy; Low level laser; Mucositis; Radiotherapy; Xerostomy

Indexed keywords

EID: 33744513677     PISSN: 01003984     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-39842006000200012     Document Type: Article

References (46)

1. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000;47:1-12.
2. Bonassa EMA. Enfermagem em quimioterapia. São Paulo: Atheneu, 1998;238.
3. Fontelonga A. Mucosite. A saúde na internet. São Paulo; 2001 [acessado em 5 nov 2001]. Disponível em: http://www.saudenainternet-rede MNI.htm
4. Carl W, Havens J. The cancer patient with severe mucositis. Curr Rev Pain 2000;3:197-202.
5. Devita VT Jr. Oral complications. In: Cancer: principles and practice of oncology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001;2881-2888.
6. Semba SE, Mealey BL, Hallmon WW. The head and neck radiotherapy patient: Part 1 - oral manifestations of radiation therapy. Compend Contin Educ Dent 1994;15:252-260.
7. Fajardo LF, Bertrong M, Anderson RE. Salivary glands In: Fajardo LF, Bertrong M, Anderson RE, editors. Radiation pathology. Minnesota: Oxford University Press, 2001;265-270.
8. Chao KS, Deasy JO, Markmon J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-916.
9. Burlage FR, Coppes RP, Meertens H, et al. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol 2001;61:271-274.
10. Roesink JM, Moerland MA, Battermann JJ, et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001;51:938-946.
11. Maes A, Weltens C, Flamen P, et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 2002;63:203-211.
12. Cheng VST, Downs J, Herbert D, Aramany M. The function of the parotid gland following radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1981;7:253-258.
13. Johnson JT, Ferreti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-395.
14. Rieke JW, Hafermann MD, Johnson JT, et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 1995;31:661-669.
15. Schuchter LM, Hensley ML, Meropal NJ, et al. 2002 Update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2002;20:2895-2903.
16. Warde P, Krall B, O'Sullivan B, et al. A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer 2000;8:203-208.
17. Antonadou D, Pepelassi M, Synodinou M, Puglisi M, Throuvalas N. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;52:739-747.
18. Epstein JB, Schubert MM. Synergistic effect of sialagogues in management of xerostomia after radiation therapy. Oral Surg Oral Med Oral Pathol 1987;64:179-182.
19. Schubert MM, Franquini JC, Niccoli-Filho F, et al. Effects of low-energy laser on oral mucositis: a phase I/II pilot study. Cancer Res Weekly 1994;7:14.
20. Brugnera Jr A, Pinheiro ALB. Lasers na odontologia moderna. São Paulo, SP: Pancast, 1998.
21. Tunér J, Hode L. Low level laser therapy. Graengesberg, Sweden: Prima Books, 1999;403.
22. Maldonado EP. Mecanismos de interação laser-tecido [apostila do curso de mestrado profissionalizante de lasers em odontologia do Ipen]. São Paulo, SP: Ipen, 2000.
23. Cisneros JLV. Láser y fuentes de luz pulsada intensa em dermatología y dermocosmética. Madrid: Aula Médica Ediciones, 2000.
24. Takeda Y. Irradiation effect of low-energy laser on rat submandibular salivary gland. J Oral Pathol 1988;17:91-94.
25. Bortolleto R. Efeito da radiação do laser de baixa potência no potencial de membrana de mitocôndrias em células in-vitro. (Dissertação de Mestrado). São José dos Campos, SP: Universidade do Vale do Paraíba, 2000.
26. Rigau J. Acción de la luz láser a baja densidad en la modulación de la función celular. (Tesis de Doctorado). Reus-Tarragona. Espanha: Universidad Rovira y Virgili, 1996.
27. Karu TI. Photobiological fundamentals of low-power laser therapy. J Quantum Electronics Moscow 1987;QE-23(10):1703-1717.
28. Mester AF, Mester A. Wound healing. Laser Therapy 1989;1:7-15.
29. Hashieh IA, Tardieu C, Franquin JC. Helium-neon laser irradiation is not a stressful treatment: a study on heat-shock protein (HSP70) level. Lasers Surg Med 1997;4 :451-460.
30. Genovese WJ. Laser de baixa intensidade: aplicações terapêuticas em odontologia. São Paulo, SP: Lovise, 2000.
31. Barasch A, Peterson DE, Tanzer JM, et al. Helium-neon laser effects on conditioning induced oral mucositis in bone marrow transplantation patients. Cancer 1995;76:2550-2556.
32. Cowen D, Tardieu C, Schubert M, et al. Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 1997;38:697-703.
33. Bensadoun RJ, Franquin JC, Ciais G. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer 1999;7:244-252.
34. Plevová P. Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis: a review. Oral Oncol 1999;5:453-470.
35. Balakirev SA, Gusev LI, Kasanova MB, et al. Low-intensity laser therapy in pediatric oncology. Vopr Onkol 2000;46:459-461.
36. Fructuoso FJG, Moset J M. Randomized double blind study on biostimulatory effect of laser irradiation of the parotid gland in patients suffering of Sjögren syndrome. Invest y Clinica Laser 1987;1:18-25.
37. Nagasawa A. Application of LLLT in dentistry. In: Ohshiro T, editor. Low-reactive laser therapy. Practical applications. London: John Wiley & Sons, 1991;76.
38. Kats AG. Low-energy laser radiation in the combined treatment of salivary gland inflammation. Stomatologia (Mosk) 1993;4:32-36.
39. Kats AG, Belastotskaia IM, Malamud ZP, et al. Remote results of the complex treatment of chronic sialadenitis using the helium-neon laser. Vestnik Khimrgii Imeni I-I Grekova 1985;135:39-42.
40. Hall EJ. Radiobiology for the radiologist. 4th ed. Philadelphia, PA: JB Lippincott, 1994;1-13.
41. Bentel GC. Radiation therapy planning. 2nd ed. New York, NY: McGraw-Hill, 1996;268-330.
42. Perez CA, Brady LW. Principles and practice of radiation oncology. 3rd ed. Philadelphia, PA: Lippincott-Raven, 1998;981-1002.
43. Leibel SA, Phillips TL. Textbook of radiation oncology. Philadelphia, PA: WB Saunders, 1998;412-526.
44. Gomes R. Oncologia básica. Rio de Janeiro, RJ: Revinter, 1997.
45. Radiation Therapy Oncology Group. A phase III study to test the efficacy of the prophylatic use of oral pilocarpine to reduce hyposalivation and mucositis associated with curative radiation therapy in head and neck cancerpatients. RTOG97-09. Philadelphia, PA: Radiation Therapy Oncology Group, 1999.
46. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. An improved reference for grading the effects of cancer treatment: impact on radiotherapy. Int J Radiat Biol Oncol Phys 2000;47:13-47.